IJSHR

International Journal of Science and Healthcare Research

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Original Research Article

Year: 2018 | Month: October-December | Volume: 3 | Issue: 4 | Pages: 99-105

Pulmonary Diseases in Hypertensive Patients: A Study in Tertiary Care Hospital

Sulfeena T P1, Bharathi D R2, Nataraj G. R3, N.Gowthami4

1Pharm D Intern, SJM College of Pharmacy, Chitradurga-577502,
2Professor, SJM College of pharmacy, Chitradurga, 577502
3Asst. Professor, Department of Pharmacology, SJM College of pharmacy, Chitradurga. 577502.
4Pharm D Intern, SJM College of Pharmacy, Chitradurga-577502,

Corresponding Author: Sulfeena T.P

ABSTRACT

Background: Chronic respiratory disease is a leading cause of morbidity and mortality worldwide. Pulmonary disease is the common co-morbidity in Hypertensive patients.
Objectives: To study the prevalence, risk factors and management of Pulmonary disease in Hypertensive patients.
Methodology: A prospective observational study was carried out for a period of six months at Medicine department of Basaveshwara Medical College & Hospital, Chitradurga.
Results: A total of 126 patients were enrolled for the study. Out of 126 Hypertensive patients 66 were also diagnosed with Pulmonary disease. Among them males 44 were more prone to develop pulmonary disease as compared to the females22.Pulmonary diseasewas mostly seen between age group of 61-70 (36.3%) in males and 71-80 (10.6%) in females. Major risk factors for Pulmonary disease in Hypertensive patient was history of alcohol consumption and smoking. Selective b-2 agonist(Salbutamol 24%), followed by combination of Penicillin+b-lactamase inhibitors (Piperacillin+Tazobactam 41.8%) and Calcium channel blockers (Amlodipine 37.6%) were commonly prescribed drugs during the study period. The main drug related problems in Pulmonary disease with Hypertensive patients was found to be drug interactions, followed by adverse drug reaction, contraindication, inappropriate drug use, inappropriate dose.
Conclusion: The study reveals a high prevalence of Pulmonary disease in Hypertension with risk factors of age, gender, history of alcohol consumption and smoking. Antiasthmatics, Antimicrobials and Calcium channel blockers were commonly prescribed drugs in this study.

Keywords: Pulmonary disease, Calcium channel blockers, Adverse drug reaction, Contraindication.

[PDF Full Text]